19 articles, transcripts, and reports
Business Overview Amarin Corporation plc (NASDAQ: AMRN) is a global pharmaceutical company dedicated to reducing the cardiovascular disease (CVD) burden...
Amarin Corporation plc (NASDAQ: AMRN) Q2 2022 Earnings Conference
Amarin Corporation plc (NASDAQ: AMRN) Q1 2022 Earnings Conference
Amarin Corporation plc (NASDAQ: AMRN) Q4 2021 Earnings Conference
Amarin Corporation plc (NASDAQ: AMRN) Q3 2021 Earnings Conference
Amarin Corporation plc (NASDAQ: AMRN) Q2 2021 Earnings Conference
Amarin Corporation plc (NASDAQ: AMRN) Q1 2021 Earnings Conference
Amarin Corporation plc (NASDAQ: AMRN) Q3 2020 earnings call dated Nov. 05, 2020 Corporate Participants: Elisabeth Schwartz — Senior Director, Investor Relations John Thero — President and Chief Executive…
Amarin Corporation plc (NASDAQ: AMRN) Q2 2020 earnings call dated Aug. 04, 2020 Corporate Participants: Elisabeth Schwartz — Senior Director of Investor Relations John Thero — President and Chief…
Amarin (NASDAQ: AMRN) reported second quarter 2020 results yesterday. During the earnings conference call, the management and the analysts discussed mainly the ongoing VASCEPA litigation.…
